Search results
Results from the WOW.Com Content Network
Ocrelizumab, sold under the brand name Ocrevus, is a medication used for the treatment of multiple sclerosis. It is a humanized anti-CD20 monoclonal antibody. [8] It targets CD20 marker on B lymphocytes and is an immunosuppressive drug. [10] Ocrelizumab binds to an epitope that overlaps with the epitope to which rituximab binds. [10]
Sclerotherapy is one method for the treatment of spider veins, varicose veins (which are also often treated with surgery, radiofrequency, and laser ablation), and venous malformations. In ultrasound -guided sclerotherapy, ultrasound is used to visualize the underlying vein so the physician can deliver and monitor the injection.
Pain: acute pain is mainly due to optic neuritis (with corticosteroids being the best treatment available), as well as trigeminal neuralgia, Lhermitte's sign, or dysesthesias. [154] Subacute pain is usually secondary to the disease and can be a consequence of spending too long in the same position, urinary retention, and infected skin ulcers ...
It does not include prescription drug coverage. Part C, or Medicare Advantage, is an alternative to original Medicare and provides the same basic coverage. Medicare Advantage plans may also offer ...
In general, prescription drug coverage is not included in original Medicare, although a person may enroll in a Medicare Part D plan. Some Part C (Advantage) plans also offer prescription drug ...
Sclerosis (from Ancient Greek σκληρός (sklērós) 'hard') is the stiffening of a tissue or anatomical feature, usually caused by a replacement of the normal organ-specific tissue with connective tissue. The structure may be said to have undergone sclerotic changes or display sclerotic lesions, which refers to the process of sclerosis.
There is no cure for MS. [19] Current treatments aim to mitigate inflammation and resulting symptoms from acute flares and prevent further attacks with disease-modifying medications. [ 8 ] [ 20 ] Physical therapy [ 7 ] and occupational therapy , [ 21 ] along with patient-centered symptom management, can help with people's ability to function.
Glatiramer acetate, sold under the brand name Copaxone among others, is an immunomodulator medication used to treat multiple sclerosis. [1] [2] Glatiramer acetate is approved in the United States to reduce the frequency of relapses, but not for reducing the progression of disability.